课题基金 / 基金详情

AUTOANTIBODIES IN TECHNICIANS HANDLING LUPUS BLOOD

AUTOANTIBODIES IN TECHNICIANS HANDLING LUPUS BLOOD
处理狼疮血液的技术人员中的自身抗体
批准号:
3157235
负责人:
RONALD P MESSNER
金额:
$13.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-07-01 至 1989-06-30

项目摘要

项目成果

RONALD P MESSNER的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The basic premise to be tested is that a transmissible agent capable of causing autoantibody formation is present in the blood of patients with systemic lupus erythematosus (SLE). Ample evidence now exists to support a multi-factorial etiology of SLE including genetic, hormonal and environmental influences. In terms of prevention and cure, environmental influences are potentially the most susceptible to manipulation and therefore of prime importance. In previous work we had shown that the prevalence of lymphocytotoxic antibodies (LTCA) is increased in blood and nonblood relatives of SLE patients and in technicians working with lupus blood. Others have shown increased binding of denatured DNA in lupus technicians. We believe these technicians form an ideal group in which to document the presence of a transmissible agent. Their primary exposure to SLE is through the blood they handle. Unlike SLE family members they do not share the same environment with the patient, thus the likelihood of common dietary or environmental chemicals being involved is greatly reduced. These technicians will also provide an ideal group in which to assess the risk factors involved in acquisition of autoantibodies after exposure to this agent. In phase 1 of this study we will recruit a large group of technicians with different levels of exposure to SLE blood; high, medium and low. The prevalence of LCTA and ANA will be determined in technicians as well as their spouses to search for secondary transmission. Phase two will be a case control study of these individuals comparing exposure factors in autoantibody positive and negative subjects. Finally, LCTA from asymptomatic technicians will be compared to those obtained from SLE patients with respect to the effects of these antibodies on in vitro lymphocyte function to better understand the role of these autoantibodies and the pathogenesis of SLE.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TOLEROGENIC STEM CELL TRANSPLANTATION FOR ARTHRITIS
  • 批准号:
    6171857
  • 项目类别:
  • 资助金额:
    $27.02万
  • 财政年份:
    1999
  • 负责人:
    RONALD P MESSNER
  • 依托单位:
TOLEROGENIC STEM CELL TRANSPLANTATION FOR ARTHRITIS
  • 批准号:
    6375121
  • 项目类别:
  • 资助金额:
    $27.83万
  • 财政年份:
    1999
  • 负责人:
    RONALD P MESSNER
  • 依托单位:
TOLEROGENIC STEM CELL TRANSPLANTATION FOR ARTHRITIS
  • 批准号:
    2909823
  • 项目类别:
  • 资助金额:
    $26.24万
  • 财政年份:
    1999
  • 负责人:
    RONALD P MESSNER
  • 依托单位:
TOLEROGENIC STEM CELL TRANSPLANTATION FOR ARTHRITIS
  • 批准号:
    6511923
  • 项目类别:
  • 资助金额:
    $28.67万
  • 财政年份:
    1999
  • 负责人:
    RONALD P MESSNER
  • 依托单位: